Identification and functional characterization of the natural variant MRP3-Arg1297 His of human multidrug resistance protein 3 (MRP3/ABCC3)

被引:63
|
作者
Lee, YMA
Cui, YH
König, J
Risch, A
Jäger, B
Drings, P
Bartsch, H
Keppler, D
Nies, AT [1 ]
机构
[1] Deutsch Krebsforschungszentrum, Div Tumour Biochem, D-69120 Heidelberg, Germany
[2] Deutsch Krebsforschungszentrum, Div Toxicol & Canc Risk Factors, D-69120 Heidelberg, Germany
[3] Thoraxklin Heidelberg Rohrbach, Heidelberg, Germany
来源
PHARMACOGENETICS | 2004年 / 14卷 / 04期
关键词
basolateral membrane; cholestasis; hepatocellular transporters; MRP3; polymorphism; SNP;
D O I
10.1097/00008571-200404000-00001
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The human multidrug resistance protein 3 (MRP3, symbol ABCC3) is an ATP-binding cassette transporter that mediates the efflux of organic anions, including lipophilic substances conjugated with glucuronate, sulphate or glutathione, across the basolateral membrane of polarized cells (e.g. hepatocytes) into blood. Genetic variants of MRP3 may affect the transport of these substances out of cells. The aims of this study were: (i) to identify MRP3 polymorphisms; (ii) to functionally characterize one relatively frequent MRP3 polymorphism; and (iii) to establish whether MRP3 transports bilirubin glucuronosides. Exonic nucleotide variants in the ABCC3 gene were identified by single-strand conformation polymorphism analysis. The 3890G>A mutation, resulting in MRP3-Arg(1297) His, was introduced into the ABCC3 cDNA which was stably transfected into MDCKII cells. For the functional characterization of MRP3-Arg(1297) His in comparison with MRP3, ATP-dependent transport was analysed in isolated membrane vesicles. Two non- synonymous MRP3 variants were identified with an allele frequency of 0.003 for 1643T>A (MRP3-Leu(148)Gln) and 0.08 for 3890G>A (MRP3-Arg(1297) His). Because of the high, frequency of the 3890G>A mutation, and because of the close proximity of Arg(1297) to the second nucleotide-binding domain, we pursued the functional characterization of the MRP3-Arg(1297)His polymorphic variant. MRP3-Arg(1297)His was correctly localized to the basolateral membrane of polarized MDCKII cells. We identified monoglucuronosyl bilirubin, bisgiucuronosyl bilirubin and leukotriene C-4 as substrates for both MRP3 and MRP3-Arg(1297)His. Dehydroepiandrosterone-3-sulphate and 17beta-glucuronosyl oestradiol were transported with similar kinetics by MRP3 and MRP3-Arg(1297) His. This experimental setup provides a useful tool to analyse the functional consequences of polymorphic variants of MRP3. Pharmacogenetics 14: 213-223 (C) 2004 Lippincott Williams Wilkins
引用
收藏
页码:213 / 223
页数:11
相关论文
共 50 条
  • [41] ABCC3 (MRP3)-mediated export of deoxycholic acid regulates MAPK signaling in colorectal adenoma and adenocarcinoma
    Sato, Yukihiro
    Kobayashi, Minoru
    Ohira, Masahiro
    Funayama, Ryo
    Maekawa, Masamitsu
    Karasawa, Hideaki
    Ohnuma, Shinobu
    Unno, Michiaki
    Nakayama, Keiko
    CANCER RESEARCH, 2024, 84 (06)
  • [42] Gene-wide haplotypic analysis demonstrates novel association between ATP-binding cassete 3/multidrug resistance protein 3 (ABCC3/MRP3) gene and inflammatory bowel disease
    Ho, Gwo-Tzer
    Soranzo, Nicole
    Nimmo, Elaine
    Tenesa, Albert
    Goldstein, David
    Satsangi, Jack
    GASTROENTEROLOGY, 2006, 130 (04) : A584 - A584
  • [43] Impact of Abcc2 (Mrp2) and Abcc3 (Mrp3) on the In vivo Elimination of Methotrexate and its Main Toxic Metabolite 7-hydroxymethotrexate
    Vlaming, Maria L. H.
    Pala, Zeliha
    van Esch, Anita
    Wagenaar, Els
    van Tellingen, Olaf
    de Waart, Dirk R.
    Elferink, Ronald P. J. Oude
    van de Wetering, Koen
    Schinkel, Alfred H.
    CLINICAL CANCER RESEARCH, 2008, 14 (24) : 8152 - 8160
  • [44] Up-regulation of basolateral multidrug resistance protein 3 (Mrp3) in cholestatic rat liver
    Donner, MG
    Keppler, D
    HEPATOLOGY, 2001, 34 (02) : 351 - 359
  • [45] Manifestation of Multidrug Resistance Protein 3 (MRP3) in Liver and Kidney Cells in Cholestasis: Effects of Hyperprolactinemia
    Aleksandrova, M. I.
    Kushnareva, N. S.
    Smirnova, O. V.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2013, 154 (04) : 508 - 511
  • [46] Manifestation of Multidrug Resistance Protein 3 (MRP3) in Liver and Kidney Cells in Cholestasis: Effects of Hyperprolactinemia
    M. I. Aleksandrova
    N. S. Kushnareva
    O. V. Smirnova
    Bulletin of Experimental Biology and Medicine, 2013, 154 : 508 - 511
  • [47] Induction of multidrug resistance protein 3 (Mrp3) in vivo is independent of constitutive androstane receptor.
    Cherrington, N
    Slitt, AL
    Maher, JM
    Wan, YY
    Zhang, J
    Huang, W
    Moore, DM
    Klaassen, CD
    TOXICOLOGICAL SCIENCES, 2003, 72 : 258 - 259
  • [48] Characterization of 5′-flanking region of human MRP3
    Takada, T
    Suzuki, H
    Sugiyama, Y
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 270 (03) : 728 - 732
  • [49] Enhanced expression of basolateral multidrug resistance protein isoforms Mrp3 and Mrp5 in rat liver by LPS
    Donner, MG
    Warskulat, U
    Saha, N
    Häussinger, D
    BIOLOGICAL CHEMISTRY, 2004, 385 (3-4) : 331 - 339
  • [50] The role of multidrug resistance proteins MRP1, MRP2 and MRP3 in cellular folate homeostasis
    Hooijberg, JH
    Peters, GJ
    Assaraf, YG
    Kathmann, I
    Priest, DG
    Bunni, MA
    Veerman, AJP
    Scheffer, GL
    Kaspers, GJL
    Jansen, G
    BIOCHEMICAL PHARMACOLOGY, 2003, 65 (05) : 765 - 771